• Теги
    • избранные теги
    • Компании1332
      • Показать ещё
      Разное270
      • Показать ещё
      Страны / Регионы322
      • Показать ещё
      Международные организации29
      • Показать ещё
      Показатели17
      • Показать ещё
      Формат9
      Люди16
      • Показать ещё
      Издания12
      Сферы1
19 апреля, 17:55

Lackluster J&J Q1 Pushes Healthcare ETFs Down

Johnson & Johnson continued its long streak of earnings beat but lagged our revenue estimate again on sluggish drug sales.

18 апреля, 20:55

After Johnson & Johnson Earnings, Buy These Pharma Stocks

Shares of Johnson & Johnson (JNJ) slid nearly 3.5% in morning trading Tuesday after the pharma giant's first-quarter earnings results were met with mixed reactions from investors. As the sell-off continues, investors focused on large-cap pharma companies may want to move their money into stronger options this earnings season.

18 апреля, 17:20

J&J (JNJ) Q1 Earnings Beat Estimates, Pharma Sales Slow Down

Johnson & Johnson (JNJ) reported mixed first quarter results, with earnings beating expectations while sales missing the same.

18 апреля, 15:35

Did Pharma & Biotech M&As Pick Pace in Q1?

Post-election, hopes surged that there would be an increase in M&A activity in the pharma and biotech sector in 2017.

12 апреля, 14:36

Biotech Stock Roundup: Geron Gains on Interim Data, OncoMed Slumps on Pipeline Setback

Key highlights this week included pipeline updates from companies like Geron (GERN) and OncoMed.

10 апреля, 16:30

The Zacks Analyst Blog Highlights: Johnson & Johnson, Verizon, Visa, General Dynamics and Abbott

The Zacks Analyst Blog Highlights: Johnson & Johnson, Verizon, Visa, General Dynamics and Abbott

Выбор редакции
04 апреля, 14:02

United Therapeutics Tanks, Remodulin Pump Launch Delayed

United Therapeutics Corporation (UTHR) shares plunged around 9% on Monday after the company announced that regulatory issues will delay the planned U.S. launch of RemoSynch - an implantable pump for delivering Remodulin

Выбор редакции
28 марта, 09:43

Why Is United Therapeutics (UTHR) Down 5.6% Since the Last Earnings Report?

United Therapeutics (UTHR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

24 марта, 14:47

Pharma Stock Roundup: Is Sanofi Buying Flexion? Pfizer, Merck KGaA Drug Approved

This week's highlights include rumors regarding Sanofi (SNY) acquiring Flexion, accelerated FDA approval for a Pfizer/Merck KGaA drug and drug pricing.

02 марта, 17:30

Zacks Industry Outlook Highlights: GlaxoSmithKline, Celgene and Exelixis

Zacks Industry Outlook Highlights: GlaxoSmithKline, Celgene and Exelixis

01 марта, 23:19

M&As, Pipeline Catalysts to Drive Pharma Sector

M&As, Pipeline Catalysts to Drive Pharma Sector

28 февраля, 17:30

Zacks Industry Outlook Highlights: Johnson & Johnson, Pfizer, Glaxo, Amgen's and Lilly

Zacks Industry Outlook Highlights: Johnson & Johnson, Pfizer, Glaxo, Amgen’s and Lilly

28 февраля, 00:41

Pharma Industry Outlook - February/March 2017

Pharma Industry Outlook - February/March 2017

23 февраля, 17:03

United Therapeutics (UTHR) Down on Q4 Earnings & Sales Miss

United Therapeutics Corporation (UTHR) reported adjusted earnings of $2.64 per share for fourth-quarter 2016, which missed the Zacks Consensus Estimate of $3.62 by 27.1%.

Выбор редакции
07 февраля, 15:41

4 Drug Stocks that are Broker Favorites

Here's a look at 4 drug stocks preferred by analysts who have a deep knowledge and understanding of the industry and its companies.

03 февраля, 14:54

Pharma Stock Roundup: Pfizer, Merck, LLY Report Results, Teva Hit by Copaxone Ruling

Key highlights this week include a court ruling in the Copaxone patent infringement lawsuit and earnings results from companies like Pfizer (PFE).

02 февраля, 14:27

Biotech Stock Roundup: Celgene, Biogen, ABBV Post Q4 Results, Catabasis Falls on DMD Data

Major highlights this week were earnings results from companies like Celgene (CELG) and pipeline updates.